Nanohale AG (ETR:FYB) | WebDisclosure

Basculer en Français

9797	Companies
196381	Keywords
127397	Articles
104411	Press releases

Home
Companies
Nanohale AG

PRESS RELEASE

published on 07/30/2025 at 06:30, 6 months 4 days ago

Formycon invites to conference call on 2025 half-year results and announces participation in international investor conferences in the 3rd quarter of 2025
Formycon AG to discuss 2025 half-year results in conference call and attend international investor conferences in the 3rd quarter of 2025. Details and registration info provided

Conference Call Investor Conferences Formycon AG Biosimilars 2025 Half-Year Results
BRIEF

published on 07/10/2025 at 06:35, 6 months 24 days ago

Formycon Completes Patient Enrollment for Keytruda® Biosimilar FYB206

Formycon FYB206 Keytruda® Biosimilar Development Dahlia Study
BRIEF

published on 07/10/2025 at 06:35, 6 months 24 days ago

Formycon finalise le recrutement des patients pour le biosimilaire Keytruda® FYB206

Formycon Développement De Biosimilaires FYB206 Keytruda® Étude Dahlia
PRESS RELEASE

published on 07/10/2025 at 06:30, 6 months 24 days ago

Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
Formycon completes patient enrollment for clinical development of Keytruda biosimilar FYB206. Results expected in Q1 2026. Streamlined program accelerates development

Clinical Development Biosimilar Formycon Keytruda Patient Enrollment
BRIEF

published on 07/01/2025 at 13:20, 7 months 2 days ago

Bio Usawa to Commercialize FYB201 in Sub-Saharan Africa

Formycon AG FYB201 Sub-Saharan Africa Bio Usawa Diabetic Macular Edema
BRIEF

published on 07/01/2025 at 13:20, 7 months 2 days ago

Bio Usawa va commercialiser le FYB201 en Afrique subsaharienne

Formycon AG FYB201 Afrique Subsaharienne Biographie D'Usawa Œdème Maculaire Diabétique
PRESS RELEASE

published on 07/01/2025 at 13:15, 7 months 2 days ago

Bio Usawa becomes partner for the commercialization of FYB201/ BioUcenta™ (ranibizumab) across Sub-Saharan Africa
Bio Usawa partners with Formycon AG for the commercialization of FYB201/BioUcenta™ (ranibizumab) in Sub-Saharan Africa, expanding access to ophthalmic treatment for diabetic complications

Formycon AG Commercialization FYB201 Bio Usawa BioUcenta
BRIEF

published on 06/27/2025 at 15:56, 7 months 6 days ago

Formycon Successfully Places EUR 70 Million Bond Amid High Demand

Biosimilars Investor Interest Capital Market EUR 70 Million Formycon Bond
BRIEF

published on 06/27/2025 at 15:56, 7 months 6 days ago

Formycon place avec succès une obligation de 70 millions d'euros dans un contexte de forte demande

Marché Des Capitaux Biosimilaires Intérêt Des Investisseurs Liaison Formycon 70 Millions D'euros
PRESS RELEASE

published on 06/27/2025 at 15:51, 7 months 6 days ago

Formycon increases bond volume following oversubscription – Bond 2025/2029 with a volume of EUR 70 million successfully and entirely placed
Formycon AG successfully and entirely places EUR 70 million bond 2025/2029 following oversubscription, interest rate fixed at 7.00% p.a

Formycon AG Interest Rate Oversubscription EUR 70 Million Bond 2025/2029

Accesswire

Published on 02/04/2026 at 02:15, 30 minutes ago

Future Fuels Announces $2 Million LIFE Flow-Through Offering
Published on 02/04/2026 at 00:00, 2 hours 45 minutes ago

Sintana Energy Inc. Announces VMM-37 Resolution
Published on 02/03/2026 at 23:30, 3 hours 15 minutes ago

FutureGen Industries Retains Market-Making Services
Published on 02/03/2026 at 23:12, 3 hours 33 minutes ago

Appointment of Credit Advisor for Stage 1 Operations
Published on 02/03/2026 at 22:30, 4 hours 15 minutes ago

Green Bridge Announces Closing of Non-Brokered Private Placement for Gross Proceeds of C$4 Million

View all ACCESSWIRE

EQS Group

Published on 02/04/2026 at 02:05, 40 minutes ago

Saudi Arabia Preparing for AlUla Emerging Market Economies Conference to be Held February 8-9, 2026
Published on 02/04/2026 at 00:42, 2 hours 3 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3X - Initial Director's Interest Notice
Published on 02/03/2026 at 20:57, 5 hours 48 minutes ago

EQS-Adhoc: tick Trading Software AG adjusts forecast for the current 2025/2026 fiscal year
Published on 02/03/2026 at 20:36, 6 hours 9 minutes ago

Freelance.com: Agenda de communication financière 2026-2027
Published on 02/03/2026 at 20:05, 6 hours 40 minutes ago

KHUFU'S IN EGYPT NAMED NO.1 AT MIDDLE EAST & NORTH AFRICA'S 50 BEST RESTAURANTS 2026

Les Echos

Published on 02/03/2026 at 19:18, 7 hours 26 minutes ago

Paulic Meunerie - Chiffre d'Affaires 2025
Published on 02/03/2026 at 18:00, 8 hours 45 minutes ago

Mint dépasse ses ambitions annoncées pour 2025 grâce à des succès commerciaux majeurs dans le BtoB
Published on 02/03/2026 at 17:45, 9 hours ago

Informations relatives au nombre total de droits de vote et d’actions
Published on 02/03/2026 at 17:45, 9 hours ago

Revenue growth in 2025 to €11.2m (+5%)
Published on 02/03/2026 at 17:45, 9 hours ago

Chiffre d’affaires 2025 en croissance à 11,2 M€ (+5%)

View all LES ECHOS COMFI WIRE